Advice

following a full submission:

testosterone as mucoadhesive buccal tablet 30 mg (Striant SR) is accepted for restricted use within NHSScotland as testosterone replacement therapy in men with primary or secondary hypogonadism.

It offers an alternative to other routes, including transdermal application by patches or gel, for patients who would particularly benefit from this mode of administration where intramuscular treatment is not suitable.

Download detailed advice41KB (PDF)

Download

Medicine details

Medicine name:
testosterone mucoadhesive buccal (Striant SR)
SMC ID:
128/04
Indication:
as testosterone replacement therapy in men with primary or secondary hypogonadism.
Pharmaceutical company
Ardana Bioscience
BNF chapter
Endocrine system
Submission type
Full
Status
Restricted
Date advice published:
08 November 2004